244 related articles for article (PubMed ID: 32927050)
1. Provider Attitudes Toward Risk-Based Hepatocellular Carcinoma Surveillance in Patients With Cirrhosis in the United States.
Kim NJ; Rozenberg-Ben-Dror K; Jacob DA; Rich NE; Singal AG; Aby ES; Yang JD; Nguyen V; Pillai A; Fuchs M; Moon AM; Shroff H; Agarwal PD; Perumalswami P; Chandna S; Zhou K; Patel YA; Latt NL; Wong R; Duarte-Rojo A; Lindenmeyer CC; Frenette C; Ge J; Mehta N; Yao F; Benhammou JN; Bloom PP; Leise M; Kim HS; Levy C; Barnard A; Khalili M; Ioannou GN
Clin Gastroenterol Hepatol; 2022 Jan; 20(1):183-193. PubMed ID: 32927050
[TBL] [Abstract][Full Text] [Related]
2. Practice patterns and attitudes of primary care providers and barriers to surveillance of hepatocellular carcinoma in patients with cirrhosis.
Dalton-Fitzgerald E; Tiro J; Kandunoori P; Halm EA; Yopp A; Singal AG
Clin Gastroenterol Hepatol; 2015 Apr; 13(4):791-8.e1. PubMed ID: 25019694
[TBL] [Abstract][Full Text] [Related]
3. Hepatocellular Carcinoma Surveillance Patterns and Outcomes in Patients With Cirrhosis.
Daher D; Seif El Dahan K; Cano A; Gonzales M; Ransom C; Jaurez E; Carranza O; Quirk L; Morgan T; Gopal P; Patel MS; Lieber S; Louissaint J; Cotter TG; VanWagner LB; Yang JD; Parikh ND; Yopp A; Rich NE; Singal AG
Clin Gastroenterol Hepatol; 2024 Feb; 22(2):295-304.e2. PubMed ID: 37573986
[TBL] [Abstract][Full Text] [Related]
4. Primary Care Provider Practice Patterns and Barriers to Hepatocellular Carcinoma Surveillance.
Simmons OL; Feng Y; Parikh ND; Singal AG
Clin Gastroenterol Hepatol; 2019 Mar; 17(4):766-773. PubMed ID: 30056183
[TBL] [Abstract][Full Text] [Related]
5. Surveillance Imaging and Alpha Fetoprotein for Early Detection of Hepatocellular Carcinoma in Patients With Cirrhosis: A Meta-analysis.
Tzartzeva K; Obi J; Rich NE; Parikh ND; Marrero JA; Yopp A; Waljee AK; Singal AG
Gastroenterology; 2018 May; 154(6):1706-1718.e1. PubMed ID: 29425931
[TBL] [Abstract][Full Text] [Related]
6. Surveillance of cirrhosis for hepatocellular carcinoma: systematic review and economic analysis.
Thompson Coon J; Rogers G; Hewson P; Wright D; Anderson R; Cramp M; Jackson S; Ryder S; Price A; Stein K
Health Technol Assess; 2007 Sep; 11(34):1-206. PubMed ID: 17767898
[TBL] [Abstract][Full Text] [Related]
7. Longitudinal assessment of alpha-fetoprotein for early detection of hepatocellular carcinoma in patients with cirrhosis.
Kim MN; Kim BK; Kim SU; Park JY; Ahn SH; Han KH; Kim DY
Scand J Gastroenterol; 2019 Oct; 54(10):1283-1290. PubMed ID: 31593481
[No Abstract] [Full Text] [Related]
8. Alpha-Fetoprotein Detection of Hepatocellular Carcinoma Leads to a Standardized Analysis of Dynamic AFP to Improve Screening Based Detection.
Bird TG; Dimitropoulou P; Turner RM; Jenks SJ; Cusack P; Hey S; Blunsum A; Kelly S; Sturgeon C; Hayes PC; Bird SM
PLoS One; 2016; 11(6):e0156801. PubMed ID: 27308823
[TBL] [Abstract][Full Text] [Related]
9. Validation of the Hepatocellular Carcinoma Early Detection Screening (HES) Algorithm in a Cohort of Veterans With Cirrhosis.
Tayob N; Christie I; Richardson P; Feng Z; White DL; Davila J; Corley DA; Kanwal F; El-Serag HB
Clin Gastroenterol Hepatol; 2019 Aug; 17(9):1886-1893.e5. PubMed ID: 30557738
[TBL] [Abstract][Full Text] [Related]
10. Hepatocellular Carcinoma Screening Utilising Serum Alpha-Fetoprotein Measurement and Abdominal Ultrasound Is More Effective than Ultrasound Alone in Patients with Non-viral Cirrhosis.
Worland T; Harrison B; Delmenico L; Dowling D
J Gastrointest Cancer; 2018 Dec; 49(4):476-480. PubMed ID: 28920172
[TBL] [Abstract][Full Text] [Related]
11. Alpha-Fetoprotein Measurement Benefits Hepatocellular Carcinoma Surveillance in Patients with Cirrhosis.
Chang TS; Wu YC; Tung SY; Wei KL; Hsieh YY; Huang HC; Chen WM; Shen CH; Lu CH; Wu CS; Tsai YH; Huang YH
Am J Gastroenterol; 2015 Jun; 110(6):836-44; quiz 845. PubMed ID: 25869392
[TBL] [Abstract][Full Text] [Related]
12. Cost-Effectiveness of Hepatocellular Carcinoma Surveillance: An Assessment of Benefits and Harms.
Parikh ND; Singal AG; Hutton DW; Tapper EB
Am J Gastroenterol; 2020 Oct; 115(10):1642-1649. PubMed ID: 32530829
[TBL] [Abstract][Full Text] [Related]
13. Suboptimal surveillance for and knowledge of hepatocellular carcinoma among primary care providers.
McGowan CE; Edwards TP; Luong MU; Hayashi PH
Clin Gastroenterol Hepatol; 2015 Apr; 13(4):799-804. PubMed ID: 25117773
[TBL] [Abstract][Full Text] [Related]
14. Comparison of biannual ultrasonography and annual non-contrast liver magnetic resonance imaging as surveillance tools for hepatocellular carcinoma in patients with liver cirrhosis (MAGNUS-HCC): a study protocol.
Kim HA; Kim KA; Choi JI; Lee JM; Lee CH; Kang TW; Ku YM; Lee SL; Park YS; Yoon JH; Kim SH; Choi MH
BMC Cancer; 2017 Dec; 17(1):877. PubMed ID: 29268722
[TBL] [Abstract][Full Text] [Related]
15. Annual contrast-enhanced magnetic resonance imaging is highly effective in the surveillance of hepatocellular carcinoma among cirrhotic patients.
Demirtas CO; Gunduz F; Tuney D; Baltacioglu F; Kani HT; Bugdayci O; Alahdab YO; Ozdogan OC
Eur J Gastroenterol Hepatol; 2020 Apr; 32(4):517-523. PubMed ID: 31524775
[TBL] [Abstract][Full Text] [Related]
16. Screening for hepatocellular carcinoma in patients with hepatitis C cirrhosis: a cost-utility analysis.
Arguedas MR; Chen VK; Eloubeidi MA; Fallon MB
Am J Gastroenterol; 2003 Mar; 98(3):679-90. PubMed ID: 12650806
[TBL] [Abstract][Full Text] [Related]
17. An assessment of benefits and harms of hepatocellular carcinoma surveillance in patients with cirrhosis.
Atiq O; Tiro J; Yopp AC; Muffler A; Marrero JA; Parikh ND; Murphy C; McCallister K; Singal AG
Hepatology; 2017 Apr; 65(4):1196-1205. PubMed ID: 27775821
[TBL] [Abstract][Full Text] [Related]
18. Use of surveillance for hepatocellular carcinoma among patients with cirrhosis in the United States.
Davila JA; Morgan RO; Richardson PA; Du XL; McGlynn KA; El-Serag HB
Hepatology; 2010 Jul; 52(1):132-41. PubMed ID: 20578139
[TBL] [Abstract][Full Text] [Related]
19. Evaluating screening approaches for hepatocellular carcinoma in a cohort of HCV related cirrhosis patients from the Veteran's Affairs Health Care System.
Tayob N; Richardson P; White DL; Yu X; Davila JA; Kanwal F; Feng Z; El-Serag HB
BMC Med Res Methodol; 2018 Jan; 18(1):1. PubMed ID: 29301497
[TBL] [Abstract][Full Text] [Related]
20. No Association Between Screening for Hepatocellular Carcinoma and Reduced Cancer-Related Mortality in Patients With Cirrhosis.
Moon AM; Weiss NS; Beste LA; Su F; Ho SB; Jin GY; Lowy E; Berry K; Ioannou GN
Gastroenterology; 2018 Oct; 155(4):1128-1139.e6. PubMed ID: 29981779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
